EBOS group has posted double-digit growth in revenue, earnings and profits over fiscal 2020, driven by the strong year-round performance of its healthcare and animal care segments.
The New Zealand-based wholesaler and distributor of healthcare, medical and pharmaceutical products said the net overall impact of COVID-19 on the group’s performance was broadly neutral for the year.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
